Polymer-Based Drug Delivery System

Polymer Transfer Technologies

Polymer-Based Drug Delivery System

Extending efficacy, Reducing toxicity

Polymer-Based Drug Delivery System is a platform technology based on biocompatible polymers that controls drug exposure in the body. Through this approach, it maintains therapeutic efficacy while reducing systemic toxicity and side effects. The technology is not limited to a specific drug and is designed as a delivery platform applicable to a wide range of therapeutics. 

POLYTAXEL®

A Proof of Platform 

: Reengineering chemotherapy through polymer delivery 

Validation of Polymer-Based Drug Delivery System applied to conventional chemotherapeutic agents showed that comparable anticancer efficacy could be maintained at lower doses than conventional formulations, while significantly reducing side effects. 

POLYTAXEL® demonstrates how a Polymer-Based Drug Delivery System platform can be used to redesign conventional anticancer therapies. 

Technology Mechanism

Polymer-Based Drug Delivery System

A carrier platform designed to reduce 
toxicity by conjugating anticancer 
agents to polyphosphazene. 

Polymer-Based Drug Delivery System

Extending efficacy, 
Reducing toxicity 

Polymer-Based Drug Delivery System is a platform technology based on biocompatible polymers that controls drug exposure in the body. Through this approach, it maintains therapeutic efficacy while reducing systemic toxicity and side effects. The technology is not limited to a specific drug and is designed as a delivery platform applicable to a wide range of therapeutics. 

POLYTAXEL®

A Proof of Platform

: Reengineering chemotherapy through polymer delivery

Validation of Polymer-Based Drug Delivery System applied to conventional chemotherapeutic agents showed that comparable anticancer efficacy could be maintained at lower doses than conventional formulations, while significantly reducing side effects. 

POLYTAXEL® demonstrates how a Polymer-Based Drug Delivery System platform can be used to redesign conventional anticancer therapies. 

Technology Mechanism

Polymer-Based
Drug Delivery System 

A carrier platform designed to reduce toxicity by
conjugating anticancer agents to polyphosphazene. 

CEO geunwoo jin
Email contact@hyundaibio.com
Tel 1544-3194    |    Fax 053-756-4055

Address  Hyundai Bioscience Co., Ltd., 8th Floor, Botanic Gate, 166, Magokdong-ro, Gangseo-gu, Seoul, 07790, Korea

PR Site

Family Sites

Copyright ⓒ 2026 HYUNDAI BIOSCIENCE All rights reserved.

CEO geunwoo jin    |    Email contact@hyundaibio.com     |    Tel 1544-3194    |    Fax 053-756-4055

Address  Hyundai Bioscience Co., Ltd., 8th Floor, Botanic Gate, 166, Magokdong-ro, Gangseo-gu, Seoul, 07790, Korea

Copyright ⓒ 2026 HYUNDAI BIOSCIENCE All rights reserved.